United Therapeutics (UTHR) News Today $440.00 -5.38 (-1.21%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$429.29 -10.71 (-2.43%) As of 10/10/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTHR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Inspire Investing LLC Trims Stock Position in United Therapeutics Corporation $UTHROctober 12 at 4:37 AM | marketbeat.comPrime Capital Investment Advisors LLC Reduces Stake in United Therapeutics Corporation $UTHROctober 12 at 3:33 AM | marketbeat.comInsider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of StockOctober 11 at 7:42 PM | marketbeat.comRBC Capital Sticks to Its Buy Rating for United Therapeutics (UTHR)October 11 at 5:25 PM | theglobeandmail.comUnited Therapeutics Corporation $UTHR Shares Bought by Galvin Gaustad & Stein LLCOctober 11 at 6:31 AM | marketbeat.comMorgan Stanley Maintains United Therapeutics (UTHR) Equal-Weight RecommendationOctober 11 at 6:10 AM | msn.comUnited Therapeutics price target raised to $435 from $328 at Morgan StanleyOctober 10 at 3:07 PM | msn.comUnited Therapeutics (NASDAQ:UTHR) Earns Hold (C+) Rating from Weiss RatingsOctober 9 at 9:33 PM | marketbeat.comMartine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) StockOctober 9 at 6:40 PM | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) CEO Sells $1,803,440.00 in StockOctober 9 at 5:34 AM | insidertrades.comUnited Therapeutics (NASDAQ:UTHR) Sets New 52-Week High - Here's What HappenedOctober 8, 2025 | marketbeat.comInsider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of StockOctober 7, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) CEO Sells $1,798,760.00 in StockOctober 7, 2025 | insidertrades.comQRG Capital Management Inc. Raises Stock Position in United Therapeutics Corporation $UTHROctober 6, 2025 | marketbeat.comPolaris Capital Management LLC Reduces Stock Position in United Therapeutics Corporation $UTHROctober 4, 2025 | marketbeat.comHilltop National Bank Takes $341,000 Position in United Therapeutics Corporation $UTHROctober 4, 2025 | marketbeat.comHow Investors Are Reacting To United Therapeutics (UTHR) Positive Phase 3 Results for Tyvaso in IPFOctober 3, 2025 | finance.yahoo.comUnited Therapeutics (NASDAQ:UTHR) CEO Sells $1,739,520.00 in StockOctober 3, 2025 | insidertrades.comLecap Asset Management Ltd. Takes $667,000 Position in United Therapeutics Corporation $UTHROctober 3, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Boosts Stake in United Therapeutics Corporation $UTHROctober 3, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 SharesOctober 2, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) EVP Sells $4,802,600.00 in StockOctober 2, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) Sets New 1-Year High - Still a Buy?October 2, 2025 | marketbeat.comBuy Rating for United Therapeutics Driven by Legal Positioning and Market Advantages Amid Patent LitigationOctober 2, 2025 | tipranks.comUnited Therapeutics (NASDAQ:UTHR) CEO Sells $1,702,520.00 in StockOctober 2, 2025 | insidertrades.comA Look Back at Therapeutics Stocks’ Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The PackOctober 2, 2025 | msn.comMichael Benkowitz Sells 22,500 Shares of United Therapeutics (NASDAQ:UTHR) StockOctober 1, 2025 | marketbeat.comUnited Therapeutics Corporation (NASDAQ:UTHR) Given Consensus Recommendation of "Moderate Buy" by BrokeragesOctober 1, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) CEO Sells $1,712,880.00 in StockSeptember 30, 2025 | insidertrades.comUnited Therapeutics Corporation $UTHR Shares Bought by Wealth Enhancement Advisory Services LLCSeptember 30, 2025 | marketbeat.comUnited Therapeutics price target raised to $580 from $560 at UBSSeptember 29, 2025 | msn.comHold Rating for United Therapeutics’ Tyvaso Amid Mixed Trial Results and Real-World Applicability ConcernsSeptember 29, 2025 | tipranks.comUnited Therapeutics Corporation $UTHR Holdings Lifted by State of Alaska Department of RevenueSeptember 29, 2025 | marketbeat.comUnited Therapeutics Corporation (UTHR) Phase 3 TETON-2 Results Conference (Transcript)September 28, 2025 | seekingalpha.comUnited Therapeutics Corporation - Special CallSeptember 28, 2025 | seekingalpha.comUnited Therapeutics Corporation (UTHR) Phase 3 TETON-2 Results - SlideshowSeptember 28, 2025 | seekingalpha.comAugustine Asset Management Inc. Makes New Investment in United Therapeutics Corporation $UTHRSeptember 27, 2025 | marketbeat.comUnited Therapeutics initiated with an Outperform at RBC CapitalSeptember 26, 2025 | msn.comRBC Capital Initiates Coverage of United Therapeutics (UTHR) with Outperform RecommendationSeptember 26, 2025 | msn.comRBC Capital Initiates Coverage of United Therapeutics (UTHR) with Outperform RecommendationSeptember 26, 2025 | msn.comBuy Rating for United Therapeutics Amid Favorable Legal Standing in Patent LitigationSeptember 26, 2025 | tipranks.comUnited Therapeutics (NASDAQ:UTHR) Earns Outperform Rating from Analysts at Royal Bank Of CanadaSeptember 26, 2025 | marketbeat.comChristopher Causey Sells 1,000 Shares of United Therapeutics (NASDAQ:UTHR) StockSeptember 26, 2025 | insidertrades.comSowell Financial Services LLC Invests $333,000 in United Therapeutics Corporation $UTHRSeptember 26, 2025 | marketbeat.comDirector Cashes In on United Therapeutics Stock Sale!September 25, 2025 | tipranks.comInsider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 1,000 Shares of StockSeptember 25, 2025 | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Sold by Ruffer LLPSeptember 25, 2025 | marketbeat.comAssenagon Asset Management S.A. Reduces Holdings in United Therapeutics Corporation $UTHRSeptember 24, 2025 | marketbeat.comUnited Therapeutics Corporation (UTHR) Presents at Bernstein 2nd Annual Global Healthcare Conference TranscriptSeptember 24, 2025 | seekingalpha.comUnited Therapeutics (NASDAQ:UTHR) Hits New 1-Year High - What's Next?September 23, 2025 | marketbeat.com Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UTHR Media Mentions By Week UTHR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼0.760.76▲Average Medical News Sentiment UTHR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼2021▲UTHR Articles Average Week Get the Latest News and Ratings for UTHR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for United Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies REGN News ALNY News BIIB News INCY News NBIX News IONS News EXEL News EXAS News BMRN News MDGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
